Video

Hep C: Public Health Achievement Requires Immediate Application of Interventions

Author(s):

We've had a 150% increase in the number of new cases of hepatitis C in the country, and almost all of those cases are among persons less than 30 years of age," John W. Ward, MD, of CDC said.

John W. Ward, MD, from the CDC said that his team has been working with the Institute of Medicine to "lay out the blueprint" for what's necessary to eliminate hepatitis C in the country. "We have the drugs that can prevent the liver disease, the liver cancer that kills people with hepatitis c, and we have interventions that can interrupt transmission. So, let's put all those together and truly eliminate this from the country," Ward said.

Ward continued to explain that some states, like New York, have already gotten the message about how hepatitis C can be eliminated and are already taking action of their own while they wait for national reporting. They’re bringing together clinicians, health system experts, policy makers, and community organizations to really develop a community-based approach to elimination.

At CROI 2017, Ward shared with MD Magazine, that researchers need to turn their attention toward the rising number of young people becoming infected with hepatitis C. "We have an opioid crises around the world, meaning many young people began using opioids and inject themselves, leading to transmission among people who are sharing that injection equipment. We've had a 150% increase in the number of new cases of hepatitis C in the country, and almost all of those cases are among persons less than 30 years of age," Ward concluded.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.